Skip to content

Comparison of analgesic effect of sufentanil combined with ropivacaine for cesarean

The influence of Internet knowledge introduction on analgesic effect after second cesarean section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024442
Enrollment
Unknown
Registered
2019-07-12
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean

Interventions

Sponsors

Quzhou Hospital Affiliated to Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients with ASA I to II who underwent caesarean section had normal liver and kidney function.

Exclusion criteria

Exclusion criteria: 1 aged less than 25 years or older than 40 years; 2 height less than 150cm or higher than 170cm; 3 body mass index higher than 35kg/m2; 4 with hypertension and other system icdiseases; 5 coagulation abnormalities; 6 there are contraindications for spinal and epidural anesthesia and analgesic medication contraindications; 7 twin or multiple pregnancies; 8 pre-eclampsia and pregnancy-induced hypertension and other obstetric abnormalities; 9 chronic pain or drug addiction; 10 mental illness.

Design outcomes

Primary

MeasureTime frame
VAS;

Secondary

MeasureTime frame
24h analgesia pump actual dose;

Countries

China

Contacts

Public ContactZheng Lihua

Quzhou Hospital Affiliated to Zhejiang Chinese Medical University

qzzhenglh@163.com+86 13205705553

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026